Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
ePrescribe
Clinic chalana ab hoga super easy—smart software ke saath!
Loans & Investments—All with Kunjesh
Business, Home, Mortgage, Personal Loans + Expert Investment Banking. Trusted since 2001. Quick approvals.
Get Started